Related Experiment Videos

[Longitudinal study of children with bronchopulmonary dysplasia treated with disodium cromoglycate]

Barbara Kassur-Siemieńska1, Bogumiła Milewska-Bobula, Hanna Dmeńska

  • 1Klinika Niemowleca, Instytut "Pomnik Centrum Zdrowia Dziecka", Warszawa.

Medycyna Wieku Rozwojowego
|November 13, 2004
PubMed

Insights

Disodium cromoglycate effectively treated bronchopulmonary dysplasia (BPD) in premature infants, significantly reducing obstructive bronchitis and improving blood-gas normalization. This offers a promising therapeutic option for chronic lung disease in neonates.

Area of Science:

  • Pediatric Pulmonology
  • Neonatology
  • Pharmacology

Context:

  • Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting premature infants.
  • Improving quality of life for premature infants with BPD is a clinical challenge.
  • Existing treatments often involve corticosteroids, with potential side effects.

Purpose:

  • To evaluate the efficacy of disodium cromoglycate in treating BPD in infants.
  • To compare outcomes in infants treated with disodium cromoglycate versus standard care.
  • To assess the drug's impact on recurrent obturative bronchitis and bronchial hyperresponsiveness.

Summary:

  • A retrospective study compared 15 premature infants with BPD treated with disodium cromoglycate to 11 controls.
  • All infants experienced recurrent obturative bronchitis and bronchial hyperresponsiveness.
  • The disodium cromoglycate group showed statistically significant improvement in bronchitis regression and blood-gas normalization.

Impact:

  • Disodium cromoglycate demonstrates significant efficacy in managing BPD-related respiratory issues in premature infants.
  • This finding suggests a potential alternative or adjunctive therapy for chronic lung disease in neonates.
  • Further research into disodium cromoglycate for BPD management is warranted.

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment